반응식
[N+:1]([C:4]1[CH:5]=[C:6](B(O)O)[CH:7]=[CH:8][CH:9]=1)([O-:3])=[O:2].[CH3:13][C:14]1[CH:18]=[C:17]([NH:19][S:20]([C:23]2[S:24][C:25](Br)=[CH:26][CH:27]=2)(=[O:22])=[O:21])[O:16][N:15]=1>>[CH3:13][C:14]1[CH:18]=[C:17]([NH:19][S:20]([C:23]2[S:24][C:25]([C:6]3[CH:7]=[CH:8][CH:9]=[C:4]([N+:1]([O-:3])=[O:2])[CH:5]=3)=[CH:26][CH:27]=2)(=[O:22])=[O:21])[O:16][N:15]=1참가 물질
3
실험 절차
N-(3-methyl-5-isoxazolyl)-5-(3-nitrophenyl)thiophene-2-sulfonamide was prepared in the same manner as described in Example 32C from 3-nitrobenzene boronic acid (362 mg, 2.17 mmol) and N-(3-methyl-5-isoxazolyl)-5-bromothiophene-2-sulfonamide (700 mg, 2.17 mmol). Purification by column chromatography using 10% MeOH/CHCl3 gave 166 mg of the pure sulfonamide (21% yield).
후처리
- customN-(3-methyl-5-isoxazolyl)-5-(3-nitrophenyl)thiophene-2-sulfonamide was prepared in the same manner
- customPurification by column chromatography
출처 및 근거
- ORD 기록
- ord-01a0424ff4f7464d85f80cd1ae1faf43
- 출처 데이터셋
- uspto-grants-1997_01
- 특허 번호
- US05594021
연결된 노트
불러오는 중…